Search Results 151-160 of 19319 for B cell lymphomas
... lymphomas with CD30 expression that have not responded to treatment or have come back. The subtypes we are studying are Diffuse Large B-Cell Lymphoma (DLBCL) ...
... lymphoma, multiple myeloma and Hodgkin's lymphoma. Dr. Slager leads the Mayo Clinic B-cell lymphoma family registry, in which more than 500 families ...
Lymphoma is a blood cancer that begins when a germ-fighting white blood cell, called a lymphocyte, mutates and rapidly multiplies. There were roughly a half ...
... lymphoma who smoked, consumed ... B-cell lymphoma and 93 of 328 of patients with follicular lymphoma, the two most common non-Hodgkin's lymphoma subtypes.
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...
People who seek care at Mayo Clinic have access to all the treatment options for T-cell lymphomas. These include chemotherapy, immunotherapy, radiation therapy, ...
Lisocabtagene maraleucel injection is used to treat large B-cell lymphoma ... cells, which have been modified to recognize and attack your cancer cells.
A new therapy for diffuse large B-cell lymphoma, an agressive blood cancer helps couple continue their love story. Learn more.
Diffuse large B-cell lymphoma is the most common type of aggressive lymphoma. Progression-free survival is an established regulatory primary end point for phase ...
Concurrent T-cell/histiocyte-rich large B-cell lymphoma ... T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas: A Study From the Bone ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.